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Abstract: Superparamagnetic iron-oxide particles (SPIO) are used in different ways as 
contrast agents for magnetic resonance imaging (MRI): Particles with high nonspecific 
uptake are required for unspecific labeling of phagocytic cells whereas those that 
target specific molecules need to have very low unspecific cellular uptake. We compared 
iron-oxide particles with different core materials (magnetite, maghemite), different 
coatings (none, dextran, carboxydextran, polystyrene) and different hydrodynamic 
diameters (20–850 nm) for internalization kinetics, release of internalized particles, 
toxicity, localization of particles and ability to generate contrast in MRI. Particle uptake 
was investigated with U118 glioma cells und human umbilical vein endothelial cells 
(HUVEC), which exhibit different phagocytic properties. In both cell types, the contrast 
agents Resovist, B102, non-coated Fe3O4 particles and microspheres were better 
internalized than dextran-coated Nanomag particles. SPIO uptake into the cells increased 
with particle/iron concentrations. Maximum intracellular accumulation of iron particles 
was observed between 24 h to 36 h of exposure. Most particles were retained in the cells 
for at least two weeks, were deeply internalized, and only few remained adsorbed at the 
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cell surface. Internalized particles clustered in the cytosol of the cells. Furthermore, all 
particles showed a low toxicity. By MRI, monolayers consisting of 5000 Resovist-labeled 
cells could easily be visualized. Thus, for unspecific cell labeling, Resovist and 
microspheres show the highest potential, whereas Nanomag particles are promising 
contrast agents for target-specific labeling.  
Keywords: iron oxide nanoparticles; magnetic resonance imaging (MRI); toxicity; uptake 
kinetics; cellular localization; iron staining; electron microscopy  
 
1. Introduction 
Small supraparamagnetic iron oxide particles are increasingly used in magnetic resonance imaging 
(MRI) either as direct contrast agents in vivo, as conjugates for monitoring specific molecules in vitro 
and in vivo, or for ex vivo-labeling of cells and tracking their fate in vivo [1,2]. As compared with  
(non-polymeric) gadolinium complexes, magnetic iron oxide particles appear to yield higher detection 
sensitivities [3,4], but have the disadvantage for molecular imaging (or the advantage to monitor 
phagocytic cells) to be rapidly internalized by phagocytosis. To stabilize iron oxide particles in 
solution and to reduce their non-specific uptake, they are commonly coated by dextran derivatives. 
However, little is known about how these modifications influence toxicity, phagocytosis and cellular 
retention of these particles.  
Therefore, we compared these properties for several supraparamagnetic particles with magnetite 
and maghemite cores and different coatings. For these studies, we used different human cell types, 
namely glioma cells that are characterized (as many other tumor cells) by a high phagocytic  
potential [5], as well as endothelial cells from human umbilical vein endothelial cells (HUVEC) with a 
supposed lower phagocytosis [6]. We analyzed the internalization kinetics of the particles, their 
cellular localization after uptake, their in vitro toxicity, and finally their contrast properties in vitro 
under the aspects of suitability for ex vivo cellular labeling and/or for selective molecular imaging for 
in vivo MRI visualization. 
2. Results and Discussion  
2.1. Comparison of Particle Internalization and Internalization Kinetics in Vitro 
Iron-oxide particles with different core materials (magnetite, maghemite), different coatings (none, 
dextran, carboxydextran, polystyrene) and different hydrodynamic diameters (20–850 nm) were 
chosen (Table 1) and their internalization was monitored initially after 12, 24, 36 and 48 h in U118 
glioma cells and HUVEC.  
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Table 1. Properties and suppliers of different iron oxide particles. 
Particle Core Coating 
Hydrodynamic 
Diameter 
Supplier 
Resovist Maghemite/ 
magnetite 
Carboxy-
dextran 
60 nm Schering  
(Berlin, Germany) 
B102 Maghemite/ 
magnetite 
Carboxymethyl-
dextran 
60 nm Dr. Norbert Buske  
(Berlin, Germany) 
Non-coated 
Fe3O4 
Magnetite None 10 nm Dr. Norbert Buske  
(Berlin, Germany) 
Microspheres 
(M310) 
30–60% Ferrite Polystyrene 310 nm Merck Estapor  
(Fontenay Sous Bois, France) 
Microspheres 
(M850) 
55–65% Ferrite Polystyrene 850 nm Merck Estapor  
(Fontenay Sous Bois, France) 
Nanomag20 
(N20) 
Magnetite Dextran 20 nm Micromod  
(Rostock, Germany) 
Nanomag70 
(N70) 
Maghemite Dextran 70 nm Micromod  
(Rostock, Germany) 
Nanomag100 
(N100) 
Maghemite Dextran 100 nm Micromod  
(Rostock, Germany) 
In both cell lines, Resovist, B102, the non-coated Fe3O4 and the two microspheres were strongly 
absorbed, whereas Nanomag20, Nanomag70 and Nanomag100 showed a low iron uptake into the cells 
(Figures 1A and 1B). 
After 24 h, uptake of nanoparticles was dependent on the iron concentration in the culture medium 
(Figure 1C). The uptake kinetics differed somewhat between the nanoparticles, however, maximal 
uptake was mostly observed between 24 h through 36 h exposure at an iron concentration of  
0.2 mg/mL (Figure 1D). Afterwards, iron content within the cells decreased slightly. Therefore, all 
subsequent cell-labeling experiments were performed with an incubation time of 24 h. To get deeper 
insight into reasons for iron particle loss after maximum absorption, we investigated the long-term 
stability of cell-labeling and the cytotoxicity of the particles. 
2.2. Long-Term Stability of Labeling in Vitro 
The long-term stability of labeling is indispensable for subsequent cell tracking experiments. 
Therefore, cells were labeled with Resovist, B102, the non-coated Fe3O4, Microsphere (0.31) and 
Microsphere (0.85) as in previous experiments (24 h and 0.2 mg Fe/mL). After 24 h, the medium was 
replaced, the cells were cultivated for a maximum time of two weeks and the iron content in the cells 
was determined (Figure 2). Of all nanoparticles investigated, Resovist showed the least iron release; 
despite the fact that the iron concentration inside the cells was higher for microsphere-labeled cells due 
to their strong iron uptake during the 24 h incubation period. Iron release from Fe3O4 labeled cells was 
higher than the release from Resovist labeled cells but still smaller than the release from B102  
labeled cells. 
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Figure 1. Internalization of different iron oxide nanoparticles (see Table 1) in human U118 
glioma cells (A, C, D) and human umbilical vein endothelial cells (HUVEC, B) after 24 h 
at an iron concentration of 0.3 mg/mL; (A, B) The microspheres (0.31 µm and 0.85 µm) 
were absorbed best, Resovist, B102 and non-coated Fe3O4 showed an equally strong high 
uptake, whereas NanomagN20, N70 and N100 were not measurably internalized; (C) Iron 
uptake after 24 h as a function of the iron/particle concentrations applied; (D) Different 
uptake kinetics were observed for the different particles at the same iron concentration  
(0.2 mg Fe/mL); however, the strongest uptake was mostly observed between 24 and 36 h;  
(A–D) n = 3 ± S.D. 
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Figure 2. Long term stability of cell-labeling by nanoparticles. U118 glioma cells were 
incubated with different iron oxide nanoparticles for 24 h at an iron concentration of  
0.2 mg/mL, washed and further cultivated. The cellular iron content was measured after 
different periods of time. Resovist showed the longest resting time, B102 the shortest. 
Initial iron concentration varied due to different initial labeling efficiencies, see Figure 1.  
n = 3 ± S.D. 
 
2.3. Cellular Toxicity and Plasma Binding 
The cellular toxicity of iron oxide nanoparticles in vitro was determined by measuring the release of 
the cytosolic enzyme lactate dehydrogenase (LDH) into the cell culture supernatants. Like in previous 
experiments, the iron concentration of all particles was 0.2 mg Fe/mL and the incubation period was  
24 h. As control for complete LDH release, one sample was lysed and its LDH value taken as  
100% toxicity. 
At 1% fetal calf serum (FCS) in the culture dishes, all iron oxide nanoparticles effected only a 
slightly release of LDH in the culture medium (Figure 3). The effect was comparable to the exposure 
to 4% dimethyl sulfoxide (DMSO).  
However, exposure of some particles (e.g., N100) to human plasma or to fibrinogen resulted in an 
aggregation of the particles (Figure 4). This should be considered when they are injected in vivo. 
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Figure 3. Toxicity of the particles as measured by the release of the cytosolic enzyme 
lactate dehydrogenase (LDH) in vitro. U118 cells were exposed to nanoparticles for 24 h at 
an iron concentration of 0.2 mg/mL at 1% fetal calf serum (FCS, heat-inactivated), and 
released LDH was quantified in the culture supernatants; LDH-activity in lysed cells 
yielded the total activity (100%). All particles produced only a slight LDH-release 
comparably to the effect of 4% dimethyl sulfoxide (DMSO). n = 3 ± S.D. 
 
Figure 4. Aggregation of N100-particles after 1 h exposure to human plasma,  
human fibrinogen (0.21 mg/mL) or phosphate-buffered saline (control), revealed by  
electron microscopy.  
 
 
2.4. Cellular Localization of Absorbed Iron Oxide Nanoparticles 
To clarify whether the nanoparticles were adsorbed at the cell surface or internalized, we visualized 
them by light microscopic Prussian Blue staining and by electron microscopy. The cells were 
incubated with different iron oxide nanoparticles (0.2 mg Fe/mL) over 24 h. In particular, the electron 
microscopy images clearly displayed that the nanoparticles were located mostly intracellular and only 
rarely at the cell surface (Figure 5, bottom). The Prussian Blue Staining pictures sustained this 
impression (Figure 5, top). In accordance to the iron measurements, highest labeling was achieved 
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with both the microspheres and no labeling was seen with the Nanomag particles. Whereas 
microspheres did not form clusters inside the cells, B102, Resovist and the non-coated Fe3O4 yielded 
large clusters diffusely distributed in the cells. Prussian blue staining or electron microscopy could not 
reveal a confinement of the clusters by specific cell organelles.  
Figure 5. Visualization of the internalized particles by light microscopy after Prussian blue 
staining (top) and electron microscopy (bottom). U118 glioma cells were exposed to the 
particles for 24 h at 0.2 mg iron/mL. All particles were internalized (examples marked with 
arrows) except Nanomag-particles N20, N70 and N100. Resovist, B102 and non-coated 
Fe3O4 clustered in the cells but the microspheres (M 850 und M 310) did not. Typical 
results from three individual incubations are shown for each. 
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2.5. MRI Visualization in Vitro 
To compare the efficiency of the labeling for MRI visualization, cells were cultivated as 
monolayers on polyethylene terephthalate (PET) membrane filters [7]. These give only a negligible 
contrast in MRI and for this reason they are also only slightly visible. Between 1000 and 100,000 cells 
were seeded on the membranes and incubated with different iron oxide nanoparticles at 0.2 mg 
iron/mL over 24 h. The internalized iron oxide nanoparticles were imaged with a T2*-weighted pulse 
sequence on a 3 Tesla MRI system (Philips, Achieva).  
Figure 6. MRI visualization of nanoparticles-labeled U118 glioma cells grown as a 
monolayer on membrane filters. Cells grown on polyethylene terephthalate (PET) 
membrane filters were labeled for 24 h with nanoparticles (0.2 mg Fe/mL) and washed. 
T2*-weighted images were generated with a 3 Tesla MRI at room temperature. Controls 
with Resovist or 100,000 unlabelled cells are negative (arrow). After labeling with 
Resovist, already 5000 cells caused a visible signal reduction. Similar results were 
obtained with microspheres (850 und 310 nm), B102 and non-coated Fe3O4 (shown only in 
one example). In contrast, Nanomag particles N20, N70 and N100 yielded no signals, even 
at high cell numbers. Typical results from three individual incubations are shown for each. 
 
 
Controls, namely cell free membranes that were incubated with the nanoparticles alone and 
membranes with cells, but without nanoparticle incubation, yielded no signals (Figure 6). In contrast, 
cells incubated with the nanoparticles Resovist, microspheres (850 and 310 nm), B102 and non-coated 
Fe3O4 showed a clearly visible labeling. Cells incubated with the nanoparticles N20, N70 and N100 
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were not detectable (Figure 6, bottom). To determine the detection threshold, we applied Resovist to 
different numbers of cells. We could show that as few as 5000 labeled cells produced a visible 
difference to both control membranes (Figure 6, top); a higher cell numbers yielded proportionally 
higher contrasts (Figure 6, center row). Thus, iron oxide nanoparticles that are highly internalized 
exhibit a high sensitivity for detection of the cells in MRI scanners; furthermore, the MRI signal 
reduction corresponds to the iron concentrations within the cells.  
3. Experimental Section 
3.1. Cell Culture, Contrast Agents and Cell Labeling 
The human glioma cell line U118 (obtained from the Deutsche Krebsforschungsinstitut, Heidelberg, 
Germany) was cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% fetal calf serum (FCS). Human umbilical vein epithelial cells (HUVEC) were cultured in 
endothelial cell basal medium (PromoCell, Heidelberg, Germany) supplemented with 5% FCS, 
0.1 ng/mL human epidermal growth factor (hEGF), 4% heparin and 1 ng/mL human basic fibroblast 
growth factor (hbFGF) under standard culture conditions (5% CO2, 95% air in humidified chamber at 
37 °C) and split every 3 days as detailed elsewhere [8,9]. 
Contrast agents were obtained from the suppliers listed in Table 1. The different iron oxide particles 
were added to the respective media described before. After incubation, cells were washed twice briefly 
with phosphate buffered saline (PBS) and the iron uptake was quantified by photometrical 
determination (see below) Alternatively, internalized iron was visualized by Prussian Blue Staining, 
electron microscopy or MRI (see below). Unlabeled cells served as controls.  
3.2. Quantification of Iron 
Cells were dissolved in 1 mL 37% hydrochloric acid (HCl) and heated at 70 °C for 10 min. After 
cooling down to room temperature, 0.1 mL-aliquots were mixed with 4.9 mL of 0.68 M citrate-0.64 M 
phosphate buffer, pH 3.1. Then, 0.1 mL of these dilutions were incubated in a 96-well plate with  
0.1 mL Spectroquant-reagent (Merck, Darmstadt, Germany; code 1.1476, 1.0001 containing 
thioglycolic acid to reduce Fe3+ to Fe2+ and the chromogenic reagent Na2[3-(2-pyridyl)-5,6-bis(4-
phenylsulfonic acid)-1,2,4-triazine]) diluted 1:50 in the above buffer. After 30 min, the bathochromic 
shift was measured by an Elisa-reader at 550 nm. Iron standards were used for calibration. 
3.3. Cell-Toxicity 
Cell-toxicity was assayed by the release of lactate dehydrogenase (LDH). After the incubation with 
the iron oxide nanoparticles, the medium was removed, and the particles and cell debris were separated 
by centrifugation. Aliquots were mixed with equal amounts of LDH assay substrate, cofactor and dye 
solutions (each time 0.02 mL; in vitro toxicology assay kit lactate dehydrogenase based, Sigma, Saint 
Louis, U.S.). The assay mixture was added to 0.12 mL medium and incubated for 25 min in darkness. 
The reaction was stopped with the aid of 0.02 mL 1 M hydrochloric acid (HCl). The resulting colored 
compound was measured photometrically at a wavelength of 490 nm. 
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3.4. Visualization by Prussian Blue Staining and Electron Microscopy 
Cells, at a confluence of 80%, were incubated with iron oxide nanoparticles in medium for 24 h. 
Thereafter, the cells were washed briefly twice in PBS and fixed with ice-cold acetone for 10 min. 
After washing in PBS, samples were stained with a filtrated 2% potassium ferrocyanide II/1 M 
hydrochloric acid mixture (ratio 1:1) for 10 min at 37 °C causing a deep blue complex. Then, cells 
were washed with PBS and subsequently counterstained with a 0.1% (w/v) solution of Nuclear Fast 
Red (Chroma, Stuttgart, Germany) in distilled water with 5% aluminium sulfate, for 1 min. After 
washing with distilled water, cells were embedded in Aquatex (Merck, Darmstadt, Germany). 
For electron microscopy, cells were grown to 80% confluence on glass slides, incubated with 
nanoparticles in medium for 24 h, washed briefly with PBS and fixed in 3% glutaraldehyde in PBS, 
pH 7.2–7.4 overnight. The cells were washed with PBS six times over a period of 2 h, then stained 
with 2% osmium tetroxide (dissolved in distilled water) for 30 min. Then the samples were dehydrated 
with increasing concentrations of ethanol and embedded in araldite [10]. The hardening lasted 4 days 
at 37 °C and an additional 1 day at 65 °C. We obtained images on a Zeiss EM 900 electron microscope. 
3.5. Magnetic Resonance Imaging (MRI) 
Different cell numbers were cultured as monolayers on polyethylene terephthalate (PET) membrane 
filters (VWR International GmbH, Darmstadt, Germany) in medium, incubated with different iron 
oxide nanoparticles for 24 h, washed twice with PBS and fixed with 4% paraformaldehyde (dissolved 
in PBS) for 20 min. The iron particles caused a signal drop in T2*-weighted MRI. All MR images 
were obtained with a 3 T clinical scanner (Philips, Achieva). A T2*-weighted pulse sequence with  
TR/TE = 1000/35, a flip angle of 50°, a spatial resolution of 0.15 mm in plane, a slice thickness of  
1.5 mm and four repetitions was used. 
4. Conclusions  
Contrast agents for Magnetic Resonance Imaging (MRI) improve the contrast of MRI images. One 
class of contrast agents are supraparamagnetic iron oxide particles (SPIOs) that produce a strongly 
varying local magnetic field and consequently enhance T2* relaxation. In this study, we investigated 
the biological properties of different nano- and micron-sized SPIOs for cellular and molecular imaging 
in two cell lines. The contrast agents Resovist, B102, non-coated Fe3O4 and microspheres showed a 
high non-specific phagocytic uptake by tumors and by endothelial cells. They are therefore well suited 
either for in vitro labeling of cells and subsequent cell tracking experiments, or for labeling of 
phagocytic cells in vivo. Resulting from our experiments, an optimized protocol for unspecific labeling 
could be developed: Iron uptake was most efficient with an iron concentration of 0.3 mg/mL in the cell 
culture medium and an incubation period of 24 h. The highest iron uptake was found for the 
microspheres; it was comparable to the uptake of Resovist included into liposomes or of Resovist in 
the presence of protamine sulfate (as reported earlier by us [11]).  
The influence of size, charge and concentration of other types of SPIOs on their uptake has 
also been investigated earlier with the human Jurkat T cell line [12]. In agreement with our results, the 
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dose-dependency was non-linear and independent of the particle size. Apparently, charge and coating 
of the particles have much larger influence on their non-specific uptake than their size. 
Long residence times of the particles inside the cells allow extended imaging procedures and are 
therefore an important criterion [13]. Our results show that most particles remain in the cells for at 
least two weeks after incubation, but differences in the release kinetics are obvious between the 
different particles. The slowest particle release was observed for Resovist. This high retention 
of Resovist in comparison to other particles (not tested here) was also reported in mesenchymal stem 
cells [14,15]. Depending on the application, cells labeled with micron-sized particles might show a 
different contrast over time in dividing cells: The fewer number of particles per cell might lead to a 
more uneven distribution of contrast among daughter cells. All investigated particles showed a low 
cellular toxicity with regard to LDH release. The toxicity of Resovist, a clinically approved contrast 
agent, does not appear to deviate substantially from the toxicity of the other particles analyzed.  
In contrast to these particles, N20, N70 and N100 Nanomag particles demonstrated a completely 
different iron uptake nature. These particles were hardly assimilated in any experiment, independent of 
the cell line used. These Nanomag particles vary in size from 20 nm to 100 nm, but this attribute seems 
to be insignificant. It is more probable that the coating of these particles is determining their iron 
uptake [16]. Therefore, these particles in combination with an appropriate coating are useful for 
specific labeling of molecular targets provided that they are not taken up by liver, spleen or  
kidneys in vivo.  
Cells grown on polyethylene terephthalate (PET) membrane filters allow an investigation of cell 
monolayers by MRI, since neither the membranes nor the cell layers (even after being incubated with 
the nanoparticles and washed) per se yield a contrast. Our MRI studies with these filters confirmed the 
quantitative chemical determination of cell-incorporated iron. By applying Resovist to a different 
number of cells, we determined the sensitivity of this membrane-monolayer method for MRI 
visualization. Already, a cell number of 5000 (or 63 ng Fe) is enough for a clear difference to the 
control membrane filters. 
In summary, the different iron oxide nanoparticles investigated demonstrated differential iron 
uptake, which can be used for diverse applications: Nanoparticles with a high non-specific uptake 
(microspheres, Resovist, B105, non-coated Fe3O4) are ideal for in vitro labeling of cells and 
subsequent cell-tracking or visualization of phagocytic cells in vivo, Nanomag particles with meager 
non-specific uptake are a starting point for specific labeling of molecular targets (molecular imaging).  
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